Paper Details 
Original Abstract of the Article :
Lanthanum carbonate (LC) is used as a phosphate binder in dialysed patients. Abdominal pain and constipation are known side effects of its use. Furthermore, in radiological studies, LC tablets are seen as intense radio-opaque deposits within the entire gastrointestinal tract-findings which can lead ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393478/

データ提供:米国国立医学図書館(NLM)

Lanthanum Carbonate: A Potential Culprit in Colonic Diverticular Disease

This study explores a potential association between lanthanum carbonate (LC), a phosphate binder used in dialysis patients, and complications arising from colonic diverticular disease. The authors present a case report of an elderly patient on peritoneal dialysis who experienced peritonitis secondary to a perforated colonic diverticulum while taking LC. They discuss the potential role of LC in worsening constipation and increasing the risk of complications from diverticular disease.

A Hidden Danger: Lanthanum Carbonate and Colonic Diverticular Disease

This study raises important concerns about the potential complications associated with the use of LC in dialysis patients. The authors' case report highlights the possible link between LC, constipation, and complications from colonic diverticular disease. This research underscores the importance of careful monitoring and appropriate management of patients taking LC, particularly those with a history of colonic diverticular disease.

A Word of Caution: Understanding the Risks of Lanthanum Carbonate

This study provides a valuable reminder of the potential side effects associated with medications, particularly those used in chronic conditions. The authors' research underscores the need for a comprehensive understanding of the risks and benefits of LC, particularly for patients with a history of colonic diverticular disease. This knowledge is crucial for making informed treatment decisions and ensuring patient safety.

Dr.Camel's Conclusion

This study serves as a reminder of the importance of carefully considering the potential side effects of medications, particularly those used in chronic conditions like kidney disease. The authors' research highlights the possible link between LC, constipation, and complications from colonic diverticular disease, emphasizing the need for vigilant monitoring and appropriate management of patients taking this medication.
Date :
  1. Date Completed 2015-04-15
  2. Date Revised 2020-09-29
Further Info :

Pubmed ID

25874091

DOI: Digital Object Identifier

PMC4393478

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.